GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...

In work conducted by Jining Medical University investigators, synthesis and optimization of a previously reported ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative: London, UK Thursday, March 27, 2025, 09:00 Hrs [I ...

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

GSK said it plans to launch the new product in ... immunocompromised, or have a medical condition that could lead to patients requiring more extensive treatment for the infection.

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...